Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of DACT1 mRNA | affects expression | 19414516
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of DACT1 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DACT1 mRNA | decreases expression | 20713471
|
C006780 |
bisphenol A |
bisphenol A affects the expression of DACT1 mRNA | affects expression | 20170705
|
C014347 |
decitabine |
[decitabine affects the methylation of DACT1 promoter] which affects the expression of DACT1 mRNA | affects expression|affects methylation | 18538736
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in decreased expression of DACT1 mRNA | decreases expression | 18242016
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA | affects cotreatment|decreases expression | 17404688
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of DACT1 mRNA | decreases expression | 20713471
|
D010081 |
Oxazolone |
Oxazolone results in decreased expression of DACT1 mRNA | decreases expression | 18242016
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA | affects cotreatment|decreases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in decreased expression of DACT1 mRNA | decreases expression | 17404688
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in increased expression of DACT1 mRNA | affects cotreatment|increases expression | 19059307
|
D012643 |
Selenium |
Selenium results in decreased expression of DACT1 mRNA | decreases expression | 19244175
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in increased expression of DACT1 mRNA | affects cotreatment|increases expression | 19059307
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in decreased expression of DACT1 mRNA | decreases expression | 18242016
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of DACT1 mRNA | increases expression | 17170073
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of DACT1 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.28 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.28 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.87 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
6.87 | 6695378 10545420 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
3.50 | 6091945 20032816 15590891 12684321 18394133 16792590 15590890 6091946 17015710 11742282 10934080 12585506 8156442 12762349 3040596 11467998 16210060 15855793 19187332 10797510 7684630 11077013 170078 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.45 | 11922910 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
5.04 | 16142846 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.87 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
11.01 | 15845082 15665606 15380490 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
11.01 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.84 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
5.84 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
5.84 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.84 | 16675129 12948864 17261762 17018787 19861407 17289903 14630087 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
5.84 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
5.84 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
5.84 | 17440819 15775269 17261762 17893378 17049068 15572757 16837676 16912660 17242785 15758505 17595753 17952589 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
5.84 | 17049068 15668708 19066611 19189212 16873071 18629630 19011961 18855134 17440819 19155303 21152245 15565566 18815881 20544844 18821012 19189210 19084267 19142967 21138602 16202921 19288272 19115204 20065188 19289846 19200415 18351453 17893378 19103187 20859285 20135344 19221464 11161223 19410462 20005174 17261762 18984771 18425577 18997820 19487384 17242785 19244106 19059307 16818667 20390343 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
5.84 | 11921183 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
4.54 | 8156442 15590891 12507178 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.48 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.94 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
3.97 | 10545420 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.52 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.60 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.60 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.60 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.01 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.68 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.68 | 19215824 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.51 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.51 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.45 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.94 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
6.94 | 16192471 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
MESH:D003092 |
Colitis |
|
Selenium |
3.79 | 17936198 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.85 | 17373747 19159591 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
1.91 | 19769572 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.38 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
7.85 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
7.85 | 12956900 15491423 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
Oxazolone |
10.21 | 12811023 15944321 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
10.21 | 17010967 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
15.04 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
15.04 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
15.04 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
2.18 | 15131321 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.73 | 9068938 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.34 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
15.50 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
15.50 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
15.50 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.15 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.40 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.40 | 17893378 20544844 19155303 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.77 | 16134523 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
4.66 | 8156442 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.01 | 16530937 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
5.77 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.00 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.00 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.24 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.20 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.96 | 14633661 10962813 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.49 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.69 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.69 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.07 | 17162251 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.70 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.06 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
10.15 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
10.15 | 14716179 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.60 | 10880147 11019492 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.87 | 17577099 15787275 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.20 | 17581917 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.17 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.17 | 19457130 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.06 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.06 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.44 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.44 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.11 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.11 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.89 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.39 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.39 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.07 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.01 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.38 | 19010910 18704418 17679729 18206229 18460780 19387464 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.49 | 18055864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.16 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.52 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.52 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.52 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.46 | 9163691 2125692 15890375 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.46 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.46 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.24 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
6.24 | 598648 1399818 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.18 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.61 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.61 | 18569708 18520028 18816296 17053015 20464547 6695378 20064080 20869020 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.61 | 16271038 21163286 20970405 16337739 7750092 20512841 15390079 11893704 1399818 17909032 9230183 10545420 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.61 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.61 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.42 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.78 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.29 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
14.29 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
14.29 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
14.29 | 16827153 19196723 14580682 19196722 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.75 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.75 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.30 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
5.30 | 17334785 12202904 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.30 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.20 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.79 | 15107826 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.19 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.51 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.51 | 16497877 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.38 | 19157545 16882708 19010910 18608210 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.28 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.55 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.11 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.11 | 19470736 19116145 17925555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
4.75 | 1670384 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.03 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.75 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.78 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.78 | 16427766 11399458 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
4.72 | 11077013 8156442 12585506 3040596 6091946 18394133 6091945 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.39 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 15758505 17823083 17893378 15579764 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.01 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
7.93 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.93 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
7.93 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.77 | 19294695 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.92 | 15087411 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
marker/mechanism |
|
| 17148581 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.97 | 10548101 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.74 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.57 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.57 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.10 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
2.10 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.10 | 16220300 15731164 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.10 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.10 | 15084515 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.81 | 10548101 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
5.65 | 14606601 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.43 | 16940033 20219652 7692837 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
5.15 | 18447907 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.41 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
4.58 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
5.31 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
5.54 | 19075512 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.44 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.37 | 19755658 10029692 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
5.54 | 19050374 19075512 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.32 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.94 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.94 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.46 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.46 | 19037991 |
MESH:D020521 |
Stroke |
|
Raloxifene |
8.72 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
8.72 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.00 | 16684133 16045194 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.33 | 17967635 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.82 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.82 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.97 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.97 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.97 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.97 | 17572228 8653321 16712894 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.04 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.94 | 17785578 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |